Daniel Anderson | Head of Commercial Partnerships

Daniel Anderson, Head of Commercial Partnerships, Invitae


World Orphan Drug Congress USA 2018 - Conference Day One @ 11:25

Genetic testing for patient engagement – shortening the diagnostic odyssey and connecting patients to research and treatments

  • No-cost genetic testing programs support patients and clinicians to gain an accurate diagnosis quicker by removing barriers to genetic testing
  • Drive patient identification, expedite trial enrollment and accelerate time to market for new therapeutics
  • Create engaged patient communities that partner biopharma and patient advocacy groups through Patient Insights Networks (PIN)

back to speakers